Fenfluramine Enrolling by Invitation Phase 3 Trials for Dravet Syndrome / Lennox Gastaut Syndrome / Epileptic Encephalopathy / Lennox-Gastaut Syndrome (LGS) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03936777A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome